Birgit Bossenmaier

Years Active: 2017-2019
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Denis M Collins, Birgit Bossenmaier, Gwendlyn Kollmorgen, Gerhard Niederfellner
Acquired Resistance to Antibody-Drug Conjugates. Cancers 11 (3) (2019)
Claudio Sustmann, Steffen Dickopf, Jörg T Regula, Hubert Kettenberger, Michael Mølhøj, Christian Gassner, Diana Weininger, Sebastian Fenn, Tobias Manigold, Lothar Kling, Klaus-Peter Künkele, Manfred Schwaiger, Birgit Bossenmaier, Julia J Griese, Karl-Peter Hopfner, Alexandra Graff-Meyer, Henning Stahlberg, Philippe Ringler, Matthias E Lauer, Ulrich Brinkmann, Wolfgang Schaefer, Christiane Neumann
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity. mAbs 11 (8) (2019)
Denis Collins, Wolfgang Jacob, Juan Miguel Cejalvo, Maurizio Ceppi, Ian James, Max Hasmann, John Crown, Andrés Cervantes, Martin Weisser, Birgit Bossenmaier
Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer. PloS one 12 (5) (2017)

Birgit Bossenmaier.css-eqlu8i{font-size:small;padding-left:4px;}